Literature DB >> 23016725

Seniors' self-administration of the Elder Abuse Suspicion Index (EASI): a feasibility study.

Mark J Yaffe1, Deborah Weiss, Maxine Lithwick.   

Abstract

This study explored the feasibility of seniors aged 65 and over with MMSE ≥24 completing the EASI-sa, a self-administrable version of the Elder Abuse Suspicion Index (EASI). A convenience sample of 210 was stratified by age, sex, and language (English and French). All completed the EASI-sa within an estimated 5 minutes, 82.9% within 2 minutes. Completion time decreased with higher education, but was not affected by age, sex, language, or measured physical or mental health. No questions went unanswered; no words were poorly understood or discomforting. The EASI-sa completion was associated with a significantly increased understanding about elder abuse (p < 0.0001).

Entities:  

Mesh:

Year:  2012        PMID: 23016725     DOI: 10.1080/08946566.2011.652930

Source DB:  PubMed          Journal:  J Elder Abuse Negl        ISSN: 0894-6566


  4 in total

Review 1.  Understanding elder abuse in family practice.

Authors:  Mark J Yaffe; Bachir Tazkarji
Journal:  Can Fam Physician       Date:  2012-12       Impact factor: 3.275

2.  Vulnerability risk index profile for elder abuse in a community-dwelling.

Authors:  XinQi Dong; Melissa A Simon
Journal:  J Am Geriatr Soc       Date:  2014-01       Impact factor: 5.562

Review 3.  Screening and detection of elder abuse: Research opportunities and lessons learned from emergency geriatric care, intimate partner violence, and child abuse.

Authors:  Scott R Beach; Christopher R Carpenter; Tony Rosen; Phyllis Sharps; Richard Gelles
Journal:  J Elder Abuse Negl       Date:  2016-09-03

4.  Development and usability evaluation of VOICES: A digital health tool to identify elder mistreatment.

Authors:  Fuad Abujarad; Davis Ulrich; Chelsea Edwards; Esther Choo; Michael V Pantalon; Karen Jubanyik; James Dziura; Gail D'Onofrio; Thomas M Gill
Journal:  J Am Geriatr Soc       Date:  2021-02-21       Impact factor: 7.538

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.